These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29886583)

  • 21. [Investigation on clinicopathologic features of lymphomatoid papulosis].
    Wang TT; Wang L; Zhang WY; Liao DY; Xu C; Liu WP; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):668-72. PubMed ID: 20078970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
    Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
    Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
    De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
    J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.
    Prieto-Torres L; Rodriguez-Pinilla SM; Onaindia A; Ara M; Requena L; Piris MÁ
    Haematologica; 2019 Feb; 104(2):226-235. PubMed ID: 30630983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants: Report of the First Case.
    Yoon HJ; Choe JY; Jeon YK
    Int J Surg Pathol; 2015 Dec; 23(8):656-61. PubMed ID: 26261101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary cutaneous CD30+ lymphoproliferative disorders].
    Calzado-Villarreal L; Polo-Rodríguez I; Ortiz-Romero PL
    Actas Dermosifiliogr; 2010 Mar; 101(2):119-28. PubMed ID: 20223154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders.
    Martires KJ; Ra S; Abdulla F; Cassarino DS
    Am J Dermatopathol; 2015 Nov; 37(11):822-33. PubMed ID: 26485239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis.
    McQuitty E; Curry JL; Tetzlaff MT; Prieto VG; Duvic M; Torres-Cabala C
    J Cutan Pathol; 2014 Feb; 41(2):88-100. PubMed ID: 24118002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
    Marschalkó M; Gyöngyösi N; Noll J; Károlyi Z; Wikonkál N; Hársing J; Kuroli E; Csomor J; Matolcsy A; Sarolta K; Szepesi Á
    J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa--an indolent lesion: report of 4 cases.
    Agarwal M; Shenjere P; Blewitt RW; Hall G; Sloan P; Pigadas N; Banerjee SS
    Int J Surg Pathol; 2008 Jul; 16(3):286-90. PubMed ID: 18387994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
    Plaza JA; Feldman AL; Magro C
    J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
    Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
    Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr Virus-Associated Lymphomatoid Papules: A Sign of Immunosuppression Resembling Lymphomatoid Papulosis.
    Hooper MJ; Lee WJ; LeWitt TM; Nguyen C; Griffin T; Chung C; Zhou XA; Guitart J
    Am J Dermatopathol; 2023 Dec; 45(12):789-800. PubMed ID: 37982462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD30 antigen expression in cutaneous inflammatory infiltrates of scabies: a dynamic immunophenotypic pattern that should be distinguished from lymphomatoid papulosis.
    Gallardo F; Barranco C; Toll A; Pujol RM
    J Cutan Pathol; 2002 Jul; 29(6):368-73. PubMed ID: 12135469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases.
    Vergier B; Beylot-Barry M; Pulford K; Michel P; Bosq J; de Muret A; Beylot C; Delaunay MM; Avril MF; Dalac S; Bodemer C; Joly P; Groppi A; de Mascarel A; Bagot M; Mason DY; Wechsler J; Merlio JP
    Am J Surg Pathol; 1998 Oct; 22(10):1192-202. PubMed ID: 9777981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features.
    Onaindia A; Montes-Moreno S; Rodríguez-Pinilla SM; Batlle A; González de Villambrosía S; Rodríguez AM; Alegre V; Bermúdez GM; González-Vela C; Piris MA
    Histopathology; 2015 May; 66(6):846-55. PubMed ID: 25131361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders.
    Franchina M; Kadin ME; Abraham LJ
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1322-5. PubMed ID: 15894695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
    Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
    Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.